Affiliation:
1. 1CDC Foundation, Atlanta, Georgia.
2. 2BLH Technologies, Rockville, Maryland.
3. 3Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland.
4. 4Tobacco Control Research Branch, NCI, NIH, Rockville, Maryland.
Abstract
Abstract
Background:
Smoking is declining, except among current menthol cigarette smokers. This study examines menthol cigarette smoking in the United States.
Methods:
Cross-sectional data from 35,279 self-respondent current adult smokers who selected menthol cigarettes as their usual type, across the 2003, 2006–2007, 2010–2011, 2014–2015, and 2018–2019 waves of the nationally-representative Tobacco Use Supplement to the Current Population Survey, were analyzed in SAS/SUDAAN. Menthol cigarette smoking among current smokers was assessed by sex, age, race/ethnicity, employment, geography, and educational attainment. Linear contrasts were used to assess trends.
Results:
Overall cigarette smoking (12.6% in 2018–2019 from 17.3% in 2003) and menthol cigarette smoking (4.0% in 2018–2019 from 4.7% in 2003) in the population decreased in 2018–2019 from 2003 (both P < 0.001). Using predicted marginals, adjusted by demographics, menthol smoking among current smokers increased to 33.8% in 2018–2019 from 27.9% in 2003 (P < 0.001). Among current smoking adults, increases in menthol smoking were observed among non-Hispanic Black persons (76.8% in 2018–2019 from 73.0% in 2003), young adults (37.7% in 2018–2019 from 31.7% in 2003), and women (39.6% in 2018–2019 from 32.1% in 2003).
Conclusions:
Smoking and menthol smoking in the population has decreased, yet menthol smoking among current smokers increased from 2003 to 2018–2019. Young adult, female, and non-Hispanic Black current smokers were more likely to use menthol cigarettes than their counterparts; these differences have persisted.
Impact:
Increased menthol smoking among current smokers, notably young adults, women, and non-Hispanic Black individuals, highlights the need for targeted tobacco control interventions for these health disparity populations.
Funder
U.S. Food and Drug Administration
National Cancer Institute
Publisher
American Association for Cancer Research (AACR)